Emerging markets to make up 48% of pharma growth, IMS Health says
This article was originally published in Scrip
Executive Summary
IMS Health is predicting that emerging markets will expand by $90 billion during 2009-13, contributing 48% of annual pharmaceutical market growth in 2013, a jump from 37% in 2009.